Abstract:Background and objective: Malignant primary brain tumors cause the greatest number of years of life lost than any other cancer. Grade 4 glioma is particularly devastating: The median survival without any treatment is less than six months and with standard-of-care treatment is only 14.6 months. Accurate identification of the overall survival time of patients with brain tumors is of profound importance in many clinical applications. Automated image analytics with magnetic resonance imaging (MRI) can provide insights into the prognosis of patients with brain tumors. Methods: In this paper, We propose SurvNet, a low-complexity deep learning architecture based on the convolutional neural network to classify the overall survival time of patients with brain tumors into long-time and short-time survival cohorts. Through the incorporation of diverse MRI modalities as inputs, we facilitate deep feature extraction at various anatomical sites, thereby augmenting the precision of predictive modeling. We compare SurvNet with the Inception V3, VGG 16 and ensemble CNN models on pre-operative magnetic resonance image datasets. We also analyzed the effect of segmented brain tumors and training data on the system performance. Results: Several measures, such as accuracy, precision, and recall, are calculated to examine the perfor-mance of SurvNet on three-fold cross-validation. SurvNet with T1 MRI modality achieved a 62.7 % accuracy, compared with 52.9 % accuracy of the Inception V3 model, 58.5 % accuracy of the VGG 16 model, and 54.9 % of the ensemble CNN model. By increasing the MRI input modalities, SurvNet becomes more accurate and achieves 76.5 % accuracy with four MRI modalities. Combining the segmented data, SurvNet achieved the highest accuracy of 82.4 %. Conclusions: The research results show that SurvNet achieves higher metrics such as accuracy and f1-score than the comparisons. Our research also proves that by using multiparametric MRI modalities, SurvNet is able to learn more image features and performs a better classification accuracy. We can conclude that SurvNet with the complete scenario, i.e., segmented data and four MRI modalities, achieved the best accuracy, showing the validity of segmentation information during the survival time prediction process.

A functional artificial neural network for noninvasive pretreatment evaluation of glioblastoma patients

Predicting Survival in Glioblastoma Using Gene Expression Databases: A Neural Network Analysis

Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma

A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas

A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study

Biologically informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post treatment glioblastoma

Automatic Brain Tumor Segmentation And Overall Survival Prediction Using Machine Learning Algorithms

Automated Neural Network-based Survival Prediction of Glioblastoma Patients Using Pre-operative MRI and Clinical Data

SurvNet: A low-complexity convolutional neural network for survival time classification of patients with glioblastoma

PathoGraph: An Attention-Based Graph Neural Network Capable of Prognostication Based on CD276 Labelling of Malignant Glioma Cells

Prediction of Radiosensitivity and Radiocurability Using a Novel Supervised Artificial Neural Network.

Biologically-informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post-treatment glioblastoma

A neuro evolutionary algorithm for patient calibrated prediction of survival in Glioblastoma patients

Overall Survival Time Prediction of Glioblastoma on Preoperative MRI Using Lesion Network Mapping

Segmentation of pre- and posttreatment diffuse glioma tissue subregions including resection cavities

A Neural Network Approach to Identify Glioblastoma Progression Phenotype from Multimodal MRI

'A net for everyone': fully personalized and unsupervised neural networks trained with longitudinal data from a single patient

A deep learning model for differentiating paediatric intracranial germ cell tumour subtypes and predicting survival with MRI: a multicentre prospective study

A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis, and Primary Central Nervous System Lymphoma: An External Validation Study

Artificial neural network identified a 20‐gene panel in predicting immunotherapy response and survival benefits after anti‐PD1/PD‐L1 treatment in glioblastoma patients